[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Observation
May 2006

Angiokeratoma Corporis Diffusum in a Patient With No Recognizable Enzyme Abnormalities

Author Affiliations

Author Affiliations: Department of Dermatology, University of Texas Medical Branch at Galveston.

Arch Dermatol. 2006;142(5):615-618. doi:10.1001/archderm.142.5.615
Abstract

Background  Angiokeratoma corporis diffusum is a clinical variant of angiokeratoma that is typically associated with an enzyme deficiency in the metabolism of glycoprotein, most notably Fabry disease, resulting in many other systemic manifestations.

Observations  We report a case of angiokeratoma corporis diffusum that did not have an identifiable enzyme deficiency. A review of the literature revealed few similar cases.

Conclusion  Angiokeratoma corporis diffusum without recognizable enzyme deficiencies appears to be a distinct clinical entity with a benign course.

Angiokeratomas are hyperkeratotic papules that are characterized histologically by superficial ectatic vessels with epidermal proliferation.1 They occur clinically as 1 of 5 different subtypes. Angiokeratoma corporis diffusum (ACD) occurs most typically on the lower region of the trunk, buttocks, and thighs and is usually associated with an underlying enzyme deficiency in the metabolism of glycoproteins.2 For many years, this term was used synonymously for Fabry disease, a systemic X-linked disease caused by a deficiency of the lysosomal enzyme α-galactosidase A.38 Angiokeratoma corporis diffusum is now known to occur in several other diseases related to deficiencies of enzymes that are involved in the metabolism of glycoproteins, including fucosidosis,9 sialidosis, mannosidosis,10 GM1 gangliosidosis, and Kanzaki disease.1114 Very rarely, ACD has been reported in patients with normal enzyme activity.1525 We report such a case not only with normal enzyme activity but also without evidence of any underlying systemic abnormalities. We also review the other reported cases of ACD with normal enzyme function.

REPORT OF A CASE

A 33-year-old man presented with complaints of red-purple papules in his groin that had been increasing in size and frequency since puberty. He reported that the lesions had first appeared on his elbows and knees in childhood but had then begun to develop on his penis, scrotum, buttocks, and inguinal area during puberty. These papules, although otherwise asymptomatic, caused him great cosmetic concern. They continued to increase in size and number throughout puberty and during his 20s.

The patient had no other significant medical history, specifically no renal, cardiac, or neurologic disease. A review of systems was negative for acral pain, paresthesias, edema, fever, cough, orthopnea, dyspnea, chest pain, and palpitations. The findings of his physical examination, apart from his skin, were unremarkable. His intelligence was normal to above average. He is married with 1 healthy son and has no significant family history of similar skin lesions or renal, cardiac, or neurologic disease. He works as a physician's assistant.

His skin examination revealed multiple 2- to 7-mm, red to purple, hyperkeratotic and coalescing papules on his penis, scrotum, lower abdominal area, and inguinal region and on the proximal aspect of his thighs. Similar lesions, approximately 1 to 2 mm in diameter, were evident on his knees and elbows (Figure 1 and Figure 2).

Figure 1.
Multiple hyperkeratotic, vascular papules in classic “bathing trunk” distribution.

Multiple hyperkeratotic, vascular papules in classic “bathing trunk” distribution.

Figure 2.
Inguinal area showing additional angiokeratomas.

Inguinal area showing additional angiokeratomas.

A biopsy specimen of one of the papules on his penis revealed compact orthokeratosis, epidermal acanthosis, and superficial ectatic and dilated capillaries lined by normal-appearing endothelial cells (Figure 3). Electron microscopy showed normal endothelial cells with no enlarged or laminated lysosomes (Figure 4). Enzyme analysis of a sample of our patient's leukocytes showed normal activity of α-D-galactosidase A for Fabry disease (1.2 nmol/min per milligram of protein; reference range, 0.6-2.0 nmol/min per milligram of protein). The levels of other enzymes, including α-N-acetylgalactosaminidase (Kanzaki disease), α- and β-D-mannosidase (α- and β-mannosidosis), β-D-galactosidase (GM1 gangliosidosis), and α-L-fucosidase (fucosidosis), were also within normal limits. Because of the normal activity found in the enzymes analyzed, gene mutational analysis was not performed.

Figure 3.
Histopathologic examination shows compact orthokeratosis, acanthosis, and ectatic capillaries (original magnification ×10).

Histopathologic examination shows compact orthokeratosis, acanthosis, and ectatic capillaries (original magnification ×10).

Figure 4.
Electron microscopy reveals normal endothelial cells with no abnormal lysosomes.

Electron microscopy reveals normal endothelial cells with no abnormal lysosomes.

Blood workup revealed that the serum urea nitrogen and creatinine levels, liver function, and complete blood cell count were within normal limits. A complete ophthalmologic examination, including slit-lamp evaluation, demonstrated only minimal neovascularization in the limbus but no whorled corneal opacities or lens abnormalities. The results of dipstick urinalysis were also normal. Although microscopic urinalysis did not show any casts, cells, crystals, or active urinary sediment, lipid globules, with their characteristic “Maltese crosses,” were noted on polarization (Figure 5). This latter test was repeated in a latex- and powder-free environment, with similar results. Our patient was treated with a 532-nm diode laser under diascopy, with excellent cosmetic results.

Figure 5.
Polarized microscopy of urine sample reveals several “Maltese crosses.”

Polarized microscopy of urine sample reveals several “Maltese crosses.”

COMMENT

Several different clinical variants of angiokeratomas exist. Solitary angiokeratomas typically appear on the lower extremities and are typically larger and sometimes more verrucous than other angiokeratoma variants. Multiple angiokeratomas with a clinical appearance similar to the solitary variant have also been described. Angiokeratoma of Mibelli is characteristically found on the dorsum of the hands and feet. Angiokeratomas of Fordyce are found mostly on the scrotum or vulva and are often described in middle-aged to elderly men. Angiokeratoma circumscriptum occurs as a solitary plaque of grouped papules.2

The ACD variant was first described in 1898 in 2 independent articles.4,5 Although controversy exists as to who described the entity first, the term ACD was, in fact, used synonymously with α-galactosidase A deficiency, also known as Fabry disease (occasionally referred to as Anderson-Fabry disease).26 Fabry disease is an X-linked deficiency of the lysosomal enzyme α-galactosidase A, which is involved in the catabolism of glycosphingolipids. Its systemic manifestations are related to the accumulation of glycosphingolipids in, among others, endothelial cells.68

In addition to Fabry disease, ACD has been associated with other enzyme defects including GM1 gangliosidosis (β-galactosidase deficiency), fucosidosis (α-fucosidase deficiency),9 Kanzaki disease (α-N-acetylgalactosaminidase deficiency),1114 β-mannosidosis (β-mannosidase deficiency)10 and sialidosis (sialidase deficiency). Apart from X-linked Fabry disease, all of these lysosomal enzyme defects are inherited in an autosomal recessive fashion, and they are all characterized by some degree of central nervous system dysfunction, a characteristic facies, and often mental retardation and organomegaly.614

To our knowledge, there have been 10 previously reported cases of ACD associated with “normal” enzyme function (Table). Although not all cases were confirmed by electron microscopy or a complete enzyme analysis, the clinical presentation, lack of systemic symptoms, and laboratory data all fit with this idiopathic type of ACD. It is difficult, however, to include the case of Laxmisha et al,24 since neither enzyme analysis nor electron microscopy was performed. It is possible that in their case enzyme deficiency was present but had not yet manifested itself clinically. Also, it appears as though Calzavara-Pinton et al22 have described a unique and separate entity with underlying arteriovenous malformations and an autosomal dominant type of inheritance. Finally, it is plausible that the case described by Nguyen et al25 may more accurately be classified as multiple angiokeratomas, given the lesions' lower limb predominance, verrucous nature, and large size. Angiokeratoma corporis diffusum has more classically been described as occurring “between the bellybutton and the knees.”

Table. 
Cases of Angiokeratoma Corporis Diffusum With Normal Enzyme Function
Cases of Angiokeratoma Corporis Diffusum With Normal Enzyme Function

Most cases described no systemic disease or dysmorphic facies characteristic of glycoprotein metabolism enzyme deficiencies. Exceptions include the case of Gasparini et al,20 which apparently coincidentally occurred in a young woman with Turner syndrome, and that of Gerbig et al,21 in which the symptoms were attributed to complications of asphyxia during childbirth.

Although our patient showed no symptoms or physical examination findings suggestive of underlying enzyme deficiency, he did have lipid globules in his urine sample on polarized microscopy. These findings were found on another microscopic examination in a latex-free environment. The pathogenesis of these angiokeratomas in the absence of enzyme deficiency, such as in this case, is unclear. It may represent a partial deficiency or enzyme mosaicism. Supporting evidence for this might include the appearance of lipid droplets in the urine from an otherwise healthy kidney and the lower (but within normal range) levels of enzymes in some of the above-mentioned patients or their first-degree relatives.17,19 Perhaps gene mutational analysis could be helpful in this regard, as over 200 mutations have been described in Fabry disease alone.27 Alternatively, our patient's lipid droplets may represent a very early manifestation of a glomerular disorder, such as minimal change disease.28 Regardless, his renal function will need to be monitored.

The case reported herein represents the 10th reported case of ACD associated with normal enzyme activity in which there are also no systemic abnormalities that can be attributed to disorders of glycoprotein metabolism. The cases described by Calzavara-Pinton et al22 are not included because many of them involved systemic arteriovenous fistulas and appeared to be a distinct autosomal dominant disease (Table). Also, the case by Laxmisha and colleagues has not been confirmed, as neither electron microscopy nor enzyme analysis was performed. Angiokeratoma corporis diffusum with normal enzyme activity appears to be a distinct entity with a benign course. Underlying enzyme deficiencies should be ruled out using leukocyte and/or fibroblast analysis in combination with electron microscopy. Laser therapy can be an effective treatment option for patients with ACD.

Back to top
Article Information

Correspondence: Brent Kelly, MD, Department of Dermatology, University of Texas Medical Branch at Galveston, 301 University Blvd, Galveston, TX 77555 (bckelly@utmb.edu).

Financial Disclosure: None.

Accepted for Publication: August 13, 2005.

Author Contributions:Study concept and design: B. Kelly and E. Kelly. Drafting of the manuscript: B. Kelly. Critical revision of the manuscript for important intellectual content: E. Kelly. Study supervision: E. Kelly.

References
1.
Weedon  D Vascular tumors. Skin Pathology. New York, NY Churchill Livingstone Inc2002;1007- 1008
2.
Schiller  PIItin  PH Angiokeratomas: an update. Dermatology 1996;193275- 282
PubMedArticle
3.
Fabry  H Angiokeratoma corporis diffusum—Fabry disease: historical review from the original description to the introduction of enzyme replacement therapy. Acta Paediatr Suppl 2002;913- 5
PubMedArticle
4.
Anderson  W A case of angeio-keratoma. Br J Dermatol 1898;10113- 117Article
5.
Fabry  J Ein Beitrag zur Kenntniss der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae). Arch Dermatol Syphilol 1898;43187- 201Article
6.
Desnick  RJBrady  RBarranger  J  et al.  Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003;138338- 346
PubMedArticle
7.
Möhrenschlager  MBraun-Falco  MRing  JAbeck  D Fabry disease: recognition and management of cutaneous manifestations. Am J Clin Dermatol 2003;4189- 196
PubMedArticle
8.
Breunig  FWeidemann  FBeer  M  et al.  Fabry disease: diagnosis and treatment. Kidney Int Suppl 2003; ((84)) S181- S185
PubMed
9.
Fleming  CRennie  AFallowfield  MMcHenry  PM Cutaneous manifestations of fucosidosis. Br J Dermatol 1997;136594- 597
PubMedArticle
10.
Rodriguez-Serna  MBotella-Estrada  RChabas  A  et al.  Angiokeratoma corporis diffusum associated with beta-mannosidase deficiency. Arch Dermatol 1996;1321219- 1222
PubMedArticle
11.
Kanzaki  TYokota  MIrie  FHirabayashi  YWang  AMDesnick  RJ Angiokeratoma corporis diffusum with glycopeptiduria due to deficient lysosomal alpha-N-acetylgalactosaminidase activity: clinical, morphologic, and biochemical studies. Arch Dermatol 1993;129460- 465
PubMedArticle
12.
Kanzaki  TYokota  MMizuno  NMatsumoto  YHirabayashi  Y Novel lysosomal glycoaminoacid storage disease with angiokeratoma corporis diffusum. Lancet 1989;1875- 877
PubMedArticle
13.
Kanzaki  T Lysosomal storage diseases with angiokeratoma corporis diffusum. Nippon Rinsho 1995;533062- 3067
PubMed
14.
Kodama  KKobayashi  JAbe  R  et al.  A new case of alpha-N-acetylgalactosaminidase deficiency with angiokeratoma corporis diffusum, with Meniere's syndrome and without mental retardation. Br J Dermatol 2001;144363- 368
PubMedArticle
15.
Holmes  RCFensom  AHMcKee  PCairns  RJBlack  MM Angiokeratoma corporis diffusum in a patient with normal enzyme activities. J Am Acad Dermatol 1984;10384- 387
PubMedArticle
16.
Crovato  FRebora  A Angiokeratoma corporis diffusum and normal enzyme activities. J Am Acad Dermatol 1985;12885- 886
PubMedArticle
17.
Marsden  JAllen  R Widespread angiokeratomas without evidence of metabolic disease. Arch Dermatol 1987;1231125- 1127
PubMedArticle
18.
Frappaz  AFerrier  MCHermier  CKanitakis  JThivolet  J Angiokeratoma corporis diffusum avec activité enzimatique normale. Ann Dermatol Venereol 1987;1141383- 1387
19.
Pravata  GNoto  GArico  M Angiocheratoma corporis diffusum with normal enzyme activities. G Ital Dermatol Venereol 1990;125401- 403
PubMed
20.
Gasparini  GSarchi  GCavicchini  SBertagnolio  B Angiokeratoma corporis diffusum in a patient with normal enzyme activities and Turner's syndrome. Clin Exp Dermatol 1992;1756- 59
PubMedArticle
21.
Gerbig  AWWiesmann  UGaeng  DHunziker  T Angiokeratoma corporis diffusum without associated metabolic disorder. Hautarzt 1995;46785- 788
PubMedArticle
22.
Calzavara-Pinton  PGColombi  MCarlino  A  et al.  Angiokeratoma corporis diffusum and arteriovenous fistulas with dominant transmission in the absence of metabolic disorders. Arch Dermatol 1995;13157- 62
PubMedArticle
23.
Fimiani  MMazzatenta  CRubegni  PAndreassi  L Idiopathic angiokeratoma corporis diffusum. Clin Exp Dermatol 1997;22205- 207
PubMedArticle
24.
Laxmisha  CThappa  DMKarthikeyan  K Cutaneous variant of angiokeratoma corporis diffusum. Dermatol Online J 2003;913
PubMed
25.
Nguyen  JEgbert  BMSwetter  SM Diffuse verrucous, vascular nodules on the extremities and trunk. Arch Dermatol 2004;140353- 358
PubMed
26.
Möhrenschlager  MHenkel  VRing  J Fabry disease: more than angiokeratomas. Arch Dermatol 2004;1401526- 1528
PubMedArticle
27.
Lai  LWWhitehair  OWu  MJO'Meara  MLien  YH Analysis of splice-site mutations of the alpha-galactosidase A gene in Fabry disease. Clin Genet 2003;63476- 482
PubMedArticle
28.
Hudson  JBDennis  AJ  JrGerhardt  RE Urinary lipid and the Maltese cross. N Engl J Med 1978;299586
PubMedArticle
×